SG Americas Securities, LLC - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 6 filers reported holding REGENERON PHARMACEUTICALS in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q3 2023$1,142
+155.5%
16,700
+47.8%
0.01%
+333.3%
Q2 2023$447
-67.0%
11,300
-39.6%
0.00%
-81.2%
Q1 2023$1,356
+822.4%
18,700
+6.9%
0.02%
+700.0%
Q4 2022$147
-100.0%
17,500
-30.0%
0.00%
-71.4%
Q1 2022$908,000
+75.3%
25,000
+71.2%
0.01%
+133.3%
Q4 2021$518,000
+16.9%
14,600
+105.6%
0.00%
+50.0%
Q3 2021$443,000
-64.4%
7,100
-80.9%
0.00%
-66.7%
Q2 2021$1,243,000
+586.7%
37,100
+422.5%
0.01%
+500.0%
Q1 2021$181,000
-93.5%
7,100
-67.7%
0.00%
-93.3%
Q4 2020$2,799,000
-35.1%
22,0000.0%0.02%
-44.4%
Q3 2020$4,316,000
-25.4%
22,0000.0%0.03%
-43.8%
Q2 2020$5,783,000
+79.5%
22,0000.0%0.05%
+60.0%
Q1 2020$3,222,000
+125.3%
22,000
-46.6%
0.03%
+130.8%
Q4 2019$1,430,000
+222.8%
41,2000.0%0.01%
+225.0%
Q3 2019$443,000
-51.0%
41,2000.0%0.00%
-33.3%
Q2 2019$905,000
+220.9%
41,200
+114.6%
0.01%
+100.0%
Q1 2019$282,000
+231.8%
19,200
-64.2%
0.00%
+200.0%
Q4 2018$85,000
-89.9%
53,7000.0%0.00%
-83.3%
Q3 2018$841,000
+222.2%
53,700
+22.9%
0.01%
+200.0%
Q2 2018$261,000
-48.2%
43,7000.0%0.00%
-50.0%
Q1 2018$504,000
+221.0%
43,700
+219.0%
0.00%
+300.0%
Q4 2017$157,000
-69.2%
13,7000.0%0.00%
-75.0%
Q3 2017$510,000
+736.1%
13,700
+20.2%
0.00%
Q4 2015$61,000
-4.7%
11,4000.0%0.00%
Q3 2015$64,000
-64.6%
11,400
+12.9%
0.00%
-100.0%
Q2 2015$181,00010,1000.00%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q3 2017
NameSharesValueWeighting ↓
Garda Capital Partners LP 3,500$2,880,3600.13%
GROUP ONE TRADING, L.P. 31,900$26,252,4240.09%
SIMPLEX TRADING, LLC 33,500$27,5690.02%
IMC-Chicago, LLC 26,500$21,808,4400.02%
Allianz Asset Management GmbH 12,400$10,204,7040.02%
SG Americas Securities, LLC 16,700$1,1420.01%
JANE STREET GROUP, LLC 42,400$34,893,5040.01%
JPMORGAN CHASE & CO 32,900$27,075,3840.00%
Focused Wealth Management, Inc 400$12,4410.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders